We confirmed that CD90-FITC (AbD Serotec) and CD29-PE (AbD Serotec) surface markers were positive (all >90%) in AD-MSCs whereas the CD45-PE (AbD Serotec) and CD11b-PE (AbD Serotec) surface markers were negative (all <3%) (Figure 2). Here, ITGAM is linked to Alzheimer disease.